Alexa Bio Tech Profile
Key Indicators
- Authorised Capital ₹ 4.80 Cr
- Paid Up Capital ₹ 4.80 Cr
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 7.22 Cr
- Revenue Growth -66.97%
- Profit Growth -123.18%
- Ebitda -114.66%
- Net Worth 145.66%
- Total Assets 16.27%
About Alexa Bio Tech
Alexa Bio Tech Private Limited (ABTPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 November 2009 and has a history of 15 years and two months. Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 4.80 Cr and a paid-up capital of Rs 4.80 Cr.
The company currently has active open charges totaling ₹7.22 Cr.
Om Singla, Rakesh Kumar, and Sandeep Kumar serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232CH2009PTC031889
-
Company No.
031889
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Nov 2009
-
Date of AGM
30 Sep 2015
-
Date of Balance Sheet
31 Mar 2015
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Alexa Bio Tech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Om Singla
|
Director | 25-Nov-2009 | Current |
|
Rakesh Kumar
|
Director | 25-Nov-2009 | Current |
|
Sandeep Kumar
|
Director | 16-May-2010 | Current |
Financial Performance of Alexa Bio Tech.
Alexa Bio Tech Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 66.97% decrease. The company also saw a substantial fall in profitability, with a 123.18% decrease in profit. The company's net worth Soared by an impressive increase of 145.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alexa Bio Tech?
In 2015, Alexa Bio Tech had a promoter holding of 89.58% and a public holding of 10.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.22 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 7.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Sep 2010 | Bank Of India | ₹7.22 Cr | Open |
How Many Employees Work at Alexa Bio Tech?
Unlock and access historical data on people associated with Alexa Bio Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alexa Bio Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alexa Bio Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
